217 related articles for article (PubMed ID: 18974552)
1. Inflammatory muscle diseases.
Mastaglia FL
Neurol India; 2008; 56(3):263-70. PubMed ID: 18974552
[TBL] [Abstract][Full Text] [Related]
2. [Pathogenesis of primary inflammatory myopathies].
Benveniste O; Squier W; Boyer O; Hilton-Jones D; Herson S
Presse Med; 2004 Nov; 33(20):1444-50. PubMed ID: 15611679
[TBL] [Abstract][Full Text] [Related]
3. Update on idiopathic inflammatory myopathies.
Briani C; Doria A; Sarzi-Puttini P; Dalakas MC
Autoimmunity; 2006 May; 39(3):161-70. PubMed ID: 16769649
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory muscle diseases: a critical review on pathogenesis and therapies.
Dalakas MC
Curr Opin Pharmacol; 2010 Jun; 10(3):346-52. PubMed ID: 20409756
[TBL] [Abstract][Full Text] [Related]
5. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].
Eymard B
Presse Med; 2003 Oct; 32(35):1656-67. PubMed ID: 14631270
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic inflammatory myopathies.
Dimachkie MM; Barohn RJ
Front Neurol Neurosci; 2009; 26():126-146. PubMed ID: 19349710
[TBL] [Abstract][Full Text] [Related]
7. Potential therapeutic targets for idiopathic inflammatory myopathies.
De Bleecker JL; Creus KK; De Paepe B
Drug News Perspect; 2006 Nov; 19(9):549-57. PubMed ID: 17220960
[TBL] [Abstract][Full Text] [Related]
8. Update on the use of intravenous immune globulin in the treatment of patients with inflammatory muscle disease.
Dalakas MC
J Clin Immunol; 1995 Nov; 15(6 Suppl):70S-75S. PubMed ID: 8613495
[TBL] [Abstract][Full Text] [Related]
9. Current Classification and Management of Inflammatory Myopathies.
Schmidt J
J Neuromuscul Dis; 2018; 5(2):109-129. PubMed ID: 29865091
[TBL] [Abstract][Full Text] [Related]
10. [New classifications and pathophysiology of the inflammatory myopathies].
Benveniste O; Dubourg O; Herson S
Rev Med Interne; 2007 Sep; 28(9):603-12. PubMed ID: 17462794
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of myositis: issues, concerns and future prospects.
Dalakas MC
Nat Rev Rheumatol; 2010 Mar; 6(3):129-37. PubMed ID: 20125096
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies.
Choi YC; Dalakas MC
Neurology; 2000 Jan; 54(1):65-71. PubMed ID: 10636127
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of inflammatory and autoimmune myopathies.
Dalakas MC
Presse Med; 2011 Apr; 40(4 Pt 2):e237-47. PubMed ID: 21411269
[TBL] [Abstract][Full Text] [Related]
14. Local expression of cytokines in idiopathic inflammatory myopathies.
Lepidi H; Frances V; Figarella-Branger D; Bartoli C; Machado-Baeta A; Pellissier JF
Neuropathol Appl Neurobiol; 1998 Feb; 24(1):73-9. PubMed ID: 9549732
[TBL] [Abstract][Full Text] [Related]
15. Clinical, immunopathologic, and therapeutic considerations of inflammatory myopathies.
Dalakas MC
Clin Neuropharmacol; 1992 Oct; 15(5):327-51. PubMed ID: 1423335
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis.
Dalakas MC
Curr Opin Neurol; 2004 Oct; 17(5):561-7. PubMed ID: 15367860
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic aspects of dermatomyositis, polymyositis and overlap myositis.
Gherardi RK
Presse Med; 2011 Apr; 40(4 Pt 2):e209-18. PubMed ID: 21376512
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic approaches in patients with inflammatory myopathies.
Dalakas MC
Semin Neurol; 2003 Jun; 23(2):199-206. PubMed ID: 12894385
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of action of intravenous immunoglobulin in inflammatory muscle disease.
Quick A; Tandan R
Curr Rheumatol Rep; 2011 Jun; 13(3):192-8. PubMed ID: 21503696
[TBL] [Abstract][Full Text] [Related]
20. Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis.
Dalakas MC
Neurology; 1998 Dec; 51(6 Suppl 5):S37-45. PubMed ID: 9851729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
